Number of harvested lymph nodes is the main prognostic factor in stage IIa colorectal cancer patients

Journal of Surgical Oncology

Volumn 106, Issue 4, 2012, Pages 469-474

  La Torre, Marco ^a   Lorenzon, Laura ^a   Pilozzi, Emanuela ^a   Barucca, Viola ^a   Cavallini, Marco ^a   Ziparo, Vincenzo ^a   Ferri, Mario ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

adjuvant therapy; number of harvested lymph nodes; prognostic factor; stage II colorectal cancer; surgery

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; COLON RESECTION; COLORECTAL CANCER; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; NUMBER OF HARVESTED LYMPH NODE; OVERALL SURVIVAL; PRIORITY JOURNAL; RECTUM RESECTION;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS;

EID: 84865126046     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23101     Document Type: Article

References (24)

1. Jemal A, Siegel R, Xu J, et al.: Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
2. Benson AB, Schrag D, Somerfield MR, et al.: American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 2004; 22: 3408-3419. (Pubitemid 41103700)
3. Compton C, Fenoglio-Preiser CM, Pettigrew N, et al.: Colorectal Working Group. American Joint Committee on Cancer prognostic factors consensus conference. Cancer 2000; 88: 1739-1757. (Pubitemid 30183160)
4. National Comprehensive Cancer Network (NCCN) Clinical practice guidelines in oncology (NCCN Guidelines TM). Colon Cancer. Version 3.2011. Available at http//:www.nccn.org.
5. Stocchi L, Fazio VW, Lavery I, et al.: Individual surgeon, pathologist, and other factors affecting lymph node harvest in stage II colon carcinoma. Is a minimum of 12 examined lymph nodes sufficient ? Ann Surg Oncol 2011; 18: 405-412.
6. Saergent D, Sobrero A, Grothey A, et al.: Evidence for cure by adjuvant therapy in colon cancer: Observations based on individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol 2009; 27: 872-877.
7. Hermanek P:, pTNM and residual tumor classifications: Problems of assessment and prognostic significance. World J Surg 1995; 19: 184-190.
8. Gunderson LL, Jessup JM, Sargent DJ, et al.: Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol 2010; 28: 264-271.
9. Gunderson LL, Jessup JM, Sargent DJ, et al.: Revised tumor and node categorization for rectal cancer based on Surveillance, Epidemiology, and End Results and rectal pooled analysis outcomes. J Clin Oncol 2010; 28: 256-263.
10. NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990; 264: 1444-1450.
11. Swanson RS, Compton CC, Stewart AK, et al.: The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 2003; 10: 65-71.
12. Tepper JE, O'Connell MJ, Niedzwiecki D, et al.: Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol 2001; 19: 157-163. (Pubitemid 32063492)
13. Goldstein NS, Sanford W, Coffey M, et al.: Lymph node recovery from colorectal resection specimens removed for adenocarcinoma. Trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Pathol 1996; 106: 209-216. (Pubitemid 26277211)
14. Wong JH, Severino R, Honnebier B, et al.: Number of nodes examined and staging accuracy in colorectal carcinoma. J Clin Oncol 1999; 17: 2896-2900. (Pubitemid 29415250)
15. Goldstein NS:, Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: Recommendation on minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol 2002; 26: 179-189. (Pubitemid 34127497)
16. Chang GJ, Rodriguez-Bigas MA, Skibber JM, et al.: Lymph Node Evaluation and Survival After Curative Resection of Colon Cancer: Systematic Review. J Natl Cancer Inst 2007; 99: 433-441. (Pubitemid 47073566)
17. Le Voyer TE, Sigurdson ER, Hanlon AL, et al.: Colon cancer survival is associated with increasing number of lymph nodes analyzed. A secondary survey of intergroup trial INT-0089. J Clin Oncol 2003; 21: 2912-2919. (Pubitemid 46621841)
18. Cotte E, Glehen O:, Lymphadenectomy for colon cancer: Is there a consensus ? Ann Surg Oncol 2009; 16: 1454-1455.
19. Joseph NE, Sigurdson ER, Hanlon AL, et al.: Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resection. Ann Surg Oncol 2003; 10: 213-218. (Pubitemid 40486952)
20. Scott KWM, Grace RH:, Detection of lymph node metastases in colorectal carcinoma before and after fat clearance. Br J Surg 1989; 76: 1165-1167. (Pubitemid 19284443)
21. Chen SL, Bilchik AJ:, More extensive nodal dissection improves survival for stages I to III of colon cancer. A population-based study. Ann Surg 2006; 244: 202-210.
22. Reinbach DH, McGregor JR, Murray GD, et al.: Effect of the surgeon's specialty interest on the type of resection performed for colorectal cancer. Dis Colon Rectum 1994; 37: 1020-1023. (Pubitemid 24311567)
23. Sobin LH, Greene FL:, TNM classification: Clarification of number of regional lymph nodes for pN0. Cancer 2001; 92: 452. (Pubitemid 32664454)
24. American Joint Committee on Cancer: AJCC cancer staging manual. New York: Springer; 2010.